Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,246 | 238 | 99.0% |
| Education | $59.99 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $879.03 | 48 | $0 (2024) |
| Hill Dermaceuticals, Inc. | $836.98 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $499.02 | 24 | $0 (2024) |
| GENZYME CORPORATION | $356.22 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $310.38 | 11 | $0 (2024) |
| PFIZER INC. | $301.44 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $270.79 | 13 | $0 (2024) |
| ABBVIE INC. | $224.56 | 11 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $188.20 | 11 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $184.58 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,827 | 70 | Hill Dermaceuticals, Inc. ($308.76) |
| 2023 | $2,196 | 77 | Hill Dermaceuticals, Inc. ($528.22) |
| 2022 | $304.80 | 14 | PFIZER INC. ($51.14) |
| 2021 | $19.43 | 1 | Galderma Laboratories, L.P. ($19.43) |
| 2020 | $171.80 | 8 | PFIZER INC. ($63.66) |
| 2019 | $805.36 | 31 | Galderma Laboratories, L.P. ($287.87) |
| 2018 | $358.64 | 15 | Galderma Laboratories, L.P. ($214.90) |
| 2017 | $623.24 | 23 | Integra LifeSciences Corporation ($172.40) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.07 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $32.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Dermatology | ||||||
| 08/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Dermatology | ||||||
| 08/07/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.31 | General |
| 08/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Hill Dermaceuticals, Inc. | Tolak (Drug) | Food and Beverage | Cash or cash equivalent | $308.76 | General |
| Category: Topical | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $45.32 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA, ARAZLO | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Dermatology | ||||||
| 07/24/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: DERMATOLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Immunology | ||||||
| 07/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: Dermatology | ||||||
| 07/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,936 | 5,272 | $607,304 | $263,177 |
| 2022 | 25 | 2,758 | 5,071 | $527,062 | $255,130 |
| 2021 | 30 | 3,347 | 5,895 | $539,446 | $313,970 |
| 2020 | 27 | 2,946 | 5,155 | $505,654 | $260,745 |
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 876 | 1,317 | $207,129 | $93,192 | 45.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 417 | 527 | $109,641 | $47,570 | 43.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 425 | 647 | $78,440 | $29,590 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 105 | $23,238 | $10,973 | 47.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 161 | 211 | $21,079 | $9,654 | 45.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 67 | 76 | $17,011 | $7,798 | 45.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 283 | 1,234 | $15,463 | $7,399 | 47.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 93 | 168 | $17,267 | $6,815 | 39.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 26 | 37 | $13,615 | $6,032 | 44.3% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 37 | 38 | $9,533 | $4,179 | 43.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 27 | $8,671 | $4,020 | 46.4% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 24 | 25 | $8,054 | $3,886 | 48.2% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 35 | 36 | $9,074 | $3,489 | 38.5% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 14 | 23 | $7,840 | $3,345 | 42.7% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 34 | 35 | $7,507 | $3,331 | 44.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $8,459 | $3,080 | 36.4% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 13 | 13 | $6,260 | $3,047 | 48.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 11 | 25 | $6,051 | $2,947 | 48.7% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 22 | 22 | $4,950 | $2,197 | 44.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 32 | 32 | $5,989 | $2,166 | 36.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 139 | $4,031 | $1,664 | 41.3% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 11 | 29 | $3,635 | $1,569 | 43.2% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 14 | $3,596 | $1,395 | 38.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 13 | 13 | $2,638 | $1,178 | 44.6% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 11 | 11 | $2,777 | $1,166 | 42.0% |
About Dr. Mark Jaffe, MD
Dr. Mark Jaffe, MD is a Dermatology healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629089107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Jaffe, MD has received a total of $6,306 in payments from pharmaceutical and medical device companies, with $1,827 received in 2024. These payments were reported across 239 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,246).
As a Medicare-enrolled provider, Jaffe has provided services to 11,987 Medicare beneficiaries, totaling 21,393 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Bethesda, MD
- Active Since 08/10/2006
- Last Updated 03/27/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1629089107
Products in Payments
- Tolak (Drug) $836.98
- DUPIXENT (Biological) $499.45
- TREMFYA (Drug) $387.59
- EPIDUO FORTE (Drug) $352.13
- Sotyktu (Drug) $310.38
- EUCRISA (Drug) $274.62
- Otezla (Drug) $222.52
- ORACEA (Drug) $202.62
- Flowable (Device) $172.40
- ILUMYA (Biological) $169.53
- OPZELURA (Drug) $165.76
- QBREXZA (Drug) $144.93
- STELARA (Biological) $140.03
- COSENTYX (Drug) $134.96
- Zoryve (Drug) $132.22
- RINVOQ (Biological) $130.32
- TALTZ (Drug) $122.98
- SOOLANTRA (Drug) $115.26
- YCANTH (Drug) $99.16
- SKYRIZI (Biological) $94.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Bethesda
Dr. Susan Walker, M.d, M.D
Dermatology — Payments: $372,925
Joseph Lee, Md, MD
Dermatology — Payments: $14,030
Nashida Beckett, M.d, M.D
Dermatology — Payments: $10,308
Dr. Thomas Hornyak, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $8,825
Dr. Caitlin Fink, D.o, D.O
Dermatology — Payments: $7,706
Anita Iyer, M.d, M.D
Dermatology — Payments: $6,925